The Global Mitogen-Activated Protein Kinase (MAPK) Inhibitors Therapeutics Market shows promising growth. Valued at USD 61.40 billion in 2022, the market is projected to reach USD 102.38 billion by 2030, expanding at a compound annual growth rate (CAGR) of 6.60% during the forecast period of 2023 to 2030. This report examines market dynamics, segmentation, drivers, restraints,...